ASSOCIATION OF GENDER WITH STENT THROMBOSIS AND SHORT- TERM MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

被引:0
|
作者
Kumar, Aneel [1 ]
Kumar, Rajesh [2 ,4 ]
Mujtaba, Mustajab [2 ]
Ahmed, Rameez [2 ]
Rahooja, Kubbra [2 ]
Rasool, Ghulam [2 ]
Talpur, Mir Fahad Hussain [2 ]
Ali, Ahsan [2 ]
Basit, Abdul [2 ]
Samad, Maryam [2 ]
Yaqoob, Salma [2 ]
Siddiqui, Maria Noor [1 ]
Wadhwani, Anesh [3 ]
Kumar, Yogesh [3 ]
Raja, Rahul [3 ]
机构
[1] SMBZAN Inst Cardiol, Quetta, Pakistan
[2] Natl Inst Cardiovasc Dis, Karachi, Pakistan
[3] Dow Univ Hlth Sci, Karachi, Pakistan
[4] Natl Inst Cardiovasc Dis NICVD, Cardiol, Karachi, Pakistan
来源
PAKISTAN HEART JOURNAL | 2022年 / 55卷 / 03期
关键词
STEMI; primary PCI; stent thrombosis; MACE; gender; ELEVATION MYOCARDIAL-INFARCTION; DRUG-ELUTING STENTS; PREDICTORS; OUTCOMES; REVASCULARIZATION; MANAGEMENT; WOMEN; MEN;
D O I
10.47144/phj.v55i3.2306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Gender has been reported to be an independent predictor of stent thrombosis (ST), however, very limited data are available regarding gender disparities in the incidence of ST after primary percutaneous coronary intervention (PCI). Therefore, the objective of this study was to compare the incidence of ST among males and females after primary PCI.Methodology: In this study, we included consecutive patients diagnosed with ST-elevation myocardial infarction undergoing primary PCI. The incidence of ST and short-term major adverse cardiovascular events (MACE) were compared between male and female cohorts.Results: The gender distribution was 21% (368) female and 79% (1388) male patients. In the unmatched cohorts of females and males, the incidence of ST was 3.3% (12) vs. 5.3% (74); p=0.102, respectively. Short-term all-cause mortality rate was 12.2% (45) vs. 8.6% (119); p=0.032 among female and male patients, respectively. After propensity matching of the baseline characteristics, the incidence of stent thrombosis was 3.3% (12) vs. 4.9% (18); p=0.263 among females and male counterparts, respectively. The short-term all-cause mortality rate was 12.2% (45) vs. 10.6% (39); p=0.487 among female and propensity-matched male cohorts, respectively. Conclusion: There are no gender-based disparities in the incidence of ST as well as short-term MACE after primary PCI. The gender of the patient itself does not determine the prognosis of the patient, but longer ischemic time, older age, and consequently higher burden of risk factors confound the effect of the female gender.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 50 条
  • [41] Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting
    Marcohno, Milena Soriano
    Simsek, Cihan
    de Boer, Sanneke P. M.
    van Domburg, Ron T.
    van Geuns, Robert-Jan
    de Jaegere, Peter
    Akkerhuis, K. Martijn
    Daemen, Joost
    Serruys, Patrick W.
    Boersma, Eric
    EUROINTERVENTION, 2012, 8 (08) : 920 - 928
  • [42] Predictive Value of Lymphocyte Based Indices to Determine Major Adverse Cardiovascular Events in Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Mohanty, Vivek
    Deora, Surender
    Kaushik, Atul
    Choudhary, Rahul
    Yadav, Dharamveer
    Singh, Kuldeep
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024,
  • [43] Association of cumulative systolic blood pressure load with cardiovascular events in patients undergoing percutaneous coronary intervention
    Kim, B. S.
    Shin, J. H.
    Kim, W.
    Kook, H.
    Lee, Y.
    Park, J. K.
    Shin, J.
    Kim, H. J.
    Park, H. C.
    Heo, R.
    Lim, Y. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [44] Association of Systemic Inflammatory Index and Systemic Inflammatory Response Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Had Primary Percutaneous Coronary Intervention
    Alshraideh, Jafar
    Al-Hawamdeh, Nemeh
    Alkanash, Heba
    CIRCULATION, 2024, 150
  • [45] Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
    Zhao, Xiaoxiao
    Liu, Chen
    Zhou, Peng
    Sheng, Zhaoxue
    Li, Jiannan
    Zhou, Jinying
    Chen, Runzhen
    Wang, Ying
    Chen, Yi
    Song, Li
    Zhao, Hanjun
    Yan, Hongbing
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [46] External validation of in-hospital major adverse cardiovascular events' predictor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Raharjo, Robert Adrianto
    Herminingsih, Susi
    Ardhianto, Pipin
    Herry, Yan
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
  • [47] Procalcitonin as a Predictor of Major Adverse Cardiovascular Events in Patients with Acute ST Elevation Myocardial Infarction Underwent Primary Percutaneous Coronary Intervention
    Yandriani, Rika
    Syukri, Muhammad
    Hariyanto, Didik
    Syafri, Masrul
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F37 - F37
  • [48] A simple score for prediction of 30-day major adverse cardiovascular events in elderly patients treated with primary percutaneous coronary intervention
    Savic, L.
    Mrdovic, I.
    Krljanac, G.
    Perunicic, J.
    Asanin, M.
    Lasica, R.
    Matic, M.
    Vasiljevic, Z.
    Ostojic, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F91 - F91
  • [49] Joint effect of platelet distribution width and stent surface area on major adverse cardiovascular events after percutaneous coronary intervention
    Zhang, Xiaofeng
    Ge, Haiyan
    Gong, Xiaoxuan
    Wang, Jing
    Li, Chunjian
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5633 - 5640
  • [50] Impact of Alcohol Consumption on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
    Yun, Junpil
    Han, Kyungdo
    Ki, You-Jeong
    Hwang, Doyeon
    Kang, Jeehoon
    Yang, Han-Mo
    Park, Kyung Woo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    Han, Jung-Kyu
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)